India  

Disheartened, says Bharat Biotech, as two chief ministers complain of slow Covaxin rollout

IndiaTimes Wednesday, 12 May 2021
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid-19: WHO accepts expression of interest for Covaxin emergency use listing

Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of..
IndiaTimes

WHO accepts Bharat Biotech's Expression of Interest for Covaxin emergency use listing

The World Health Organisation (WHO) has accepted Bharat Biotech’s expression of interest (EoI) for the emergency use listing (EUL) of India's first..
IndiaTimes

Bharat Biotech, WHO pre-submission meeting on June 23: WHO

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use..
IndiaTimes

Fact Check: No newborn calf serum in Covaxin, Health Ministry and Bharat Biotech confirm

The final vaccine does not contain newborn calf serum at all as the calf serum is not an ingredient of the final vaccine product, Health Ministry said
DNA

Covaxin Covaxin Vaccine against COVID-19

Shocking! Bihar woman gets both Covaxin, Covishield shots in 5 minutes interval - what happened next, know here

If Devi continues to show no adverse symptoms, she will be tested for antibodies after 14 days, a senior health official at AIIMS Patna has said.
DNA
New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News [Video]

New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News

Several social media users including Congress members have been sharing an RTI report that details the "ingredients" used in the India-made Covid-19 vaccine. #Covaxin #CalfSerum #FactCheck

Credit: Oneindia    Duration: 02:00Published

You Might Like


Related videos from verified sources

Covid-19: Aiims Delhi to begin Covaxin clinical trials for Children from today | Oneindia News [Video]

Covid-19: Aiims Delhi to begin Covaxin clinical trials for Children from today | Oneindia News

The screening of children for clinical trials of Covaxin will start at AIIMS in Delhi from today, days after similar trials started at AIIMS in Patna. AIIMS Delhi will conduct clinical trials of the..

Credit: Oneindia     Duration: 01:24Published
Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms  | Oneindia News [Video]

Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News

Thousands of people including Covid patients evacuated because of Cyclone Tauktae from Gujarat and Maharashtra; Bharat Biotech said that the company manufactured Covaxin is effective against the..

Credit: Oneindia     Duration: 03:39Published
Bharat Biotech responds to Delhi's Covaxin plea, says...|  Oneindia News [Video]

Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News

Covaxin's maker Bharat Biotech has refused to supply vaccine doses to Delhi, Deputy Chief Minister Manish Sisodia said today. Cong MP Rahul Gandhi hit out at the centre's push for positivity aid the..

Credit: Oneindia     Duration: 03:17Published

Related news from verified sources

ICMR: Covaxin found to be effective against Brazilian variant of virus too

The indigenously developed Covaxin is capable of fighting the Brazilian variant too, according to the latest study on Covid-19 vaccine. Earlier, Covaxin was...
IndiaTimes

Don’t fret if second dose delayed, no need to restart vaccine schedule, say experts

First-dose recipients of Covaxin don't need to restart their vaccination schedule if the gap between doses goes beyond the recommended 4-6 week interval, a top...
IndiaTimes

Vax shortage forces shutting of 100 Covaxin sites in Delhi

Hundred vaccination sites administering Covaxin to the 18-44 age-group, located at 17 schools, have been closed down by the Delhi government due to vaccine...
IndiaTimes Also reported by •Zee News